Mehra, M., Desai, S., Ruschitzka, F., & Patel, A. (2020). Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet. https://doi.org/10.1016/s0140-6736(20)31180-6

City University of New York

University of Michigan - Ann Arbor

Google

- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

- Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
- Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform
- Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial


The Lancet articles about treatment interventions of COVID-19

Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y. et al. (2020). Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet. 

DOI:https://doi.org/10.1016/S0140-6736(20)31022-9

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Biran, N., Ip, A., Ahn, J., Go, R. C., Wang, S., Mathura, S., Sinclaire, B. A., Bednarz, U., Marafelias, M., Hansen, E., Siegel, D. S., Goy, A. H., Pecora, A. L., Sawczuk, I. S., Koniaris, L. S., Simwenyi, M., Varga, D. W., Tank, L. K., Stein, A. A., … Goldberg, S. L. (2020). Tocilizumab among patients with COVID-19 in the intensive care unit: A multicentre observational study. The Lancet Rheumatology, 0(0). https://doi.org/10.1016/S2665-9913(20)30277-0

Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study

Rentsch, C. T., Devito, N. J., Mackenna, B., Morton, C. E., Bhaskaran, K., Brown, J. P., . . . Goldacre, B. (2020). Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: A population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform. The Lancet Rheumatology. doi:10.1016/s2665-9913(20)30378-7

Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform

1. Monk PD, Marsden RJ, Tear VJ, et al. Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Respiratory Medicine. 2020;0(0). doi:10.1016/S2213-2600(20)30511-7


Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Learn Before

Related